Complexities, Achievements, and Unmet Needs in the Treatment of Psoriasis

Steven R. Feldman, MD, PhD


February 15, 2022

Using the evolution of psoriasis therapies over the past several decades as a backdrop, Steven Feldman, MD, PhD, discusses the conundrums, accomplishments, and promises in the treatment of psoriasis, from the problem of patient noncompliance in the treatment of the disease's milder expressions, to the successes of current regimens for more severe forms, and finally, to the looming benefits of biosimilars.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.